Caroline C King1, Athena P Kourtis, Deborah Persaud, Julie A E Nelson, Carrie Ziemniak, Michael G Hudgens, Gerald Tegha, Charles S Chasela, Denise J Jamieson, Charles M van der Horst. 1. aDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia bDepartment of Pediatrics, Johns Hopkins University, Baltimore, Maryland, USA cDepartment of Microbiology and Immunology, School of Medicine dDepartment of Biostatistics, Gillings School of Global Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA eUNC Project-Malawi, Lilongwe, Malawi fDivision of Epidemiology and Biostatistics, University of Witwatersrand, Johannesburg, South Africa gDivision of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract
OBJECTIVE: The objective of this study is to determine whether detection of HIV infection was delayed in infants exposed to antiretroviral prophylaxis to prevent HIV transmission during breastfeeding. DESIGN: The Breastfeeding, Antiretrovirals and Nutrition (BAN) study was a randomized trial of 2369 mother-infant pairs conducted from 2004 to 2010. In addition to an intrapartum regimen, all mother-infant pairs were randomly assigned to three antiretroviral intervention arms during 28 weeks of breastfeeding: no further antiretroviral prophylaxis (control arm); infant-daily nevirapine (nevirapine arm); and maternal zidovudine, lamivudine and either nevirapine, nelfinavir or lopinavir-ritonavir (maternal arm). After breastfeeding cessation counselling and stopping the antiretroviral interventions by 28 weeks, 28 infant HIV infections occurred. METHODS: To determine whether these infections occurred during the breastfeeding and antiretroviral intervention phase but had delayed detection on the antiretroviral arms, we performed ultrasensitive (droplet digital PCR) HIV testing on infants with stored peripheral blood mononuclear cell (PBMC) specimens at 24 weeks (n = 9). RESULTS: Of the nine infants, all three on the infant nevirapine arm had detectable HIV DNA at 24 weeks, compared with two of four on the maternal antiretroviral arm and one of two on the control arm. For infants with detectable HIV at 24 weeks, the median delay in detection between the ultrasensitive and standard assays was 18.3 weeks for the nevirapine arm, 15.4 weeks for the maternal arm and 9.4 weeks for the control arm. CONCLUSION: The prolonged inability to detect HIV with standard assays in the context of postnatal antiretroviral prophylaxis suggests that early antiretrovirals may restrict HIV replication sufficiently to lead to missed diagnosis among infected infants. Therefore, repeat virologic testing is warranted beyond the WHO-recommended point of testing at 6 weeks after breastfeeding cessation.
RCT Entities:
OBJECTIVE: The objective of this study is to determine whether detection of HIV infection was delayed in infants exposed to antiretroviral prophylaxis to prevent HIV transmission during breastfeeding. DESIGN: The Breastfeeding, Antiretrovirals and Nutrition (BAN) study was a randomized trial of 2369 mother-infant pairs conducted from 2004 to 2010. In addition to an intrapartum regimen, all mother-infant pairs were randomly assigned to three antiretroviral intervention arms during 28 weeks of breastfeeding: no further antiretroviral prophylaxis (control arm); infant-daily nevirapine (nevirapine arm); and maternal zidovudine, lamivudine and either nevirapine, nelfinavir or lopinavir-ritonavir (maternal arm). After breastfeeding cessation counselling and stopping the antiretroviral interventions by 28 weeks, 28 infantHIV infections occurred. METHODS: To determine whether these infections occurred during the breastfeeding and antiretroviral intervention phase but had delayed detection on the antiretroviral arms, we performed ultrasensitive (droplet digital PCR) HIV testing on infants with stored peripheral blood mononuclear cell (PBMC) specimens at 24 weeks (n = 9). RESULTS: Of the nine infants, all three on the infantnevirapine arm had detectable HIV DNA at 24 weeks, compared with two of four on the maternal antiretroviral arm and one of two on the control arm. For infants with detectable HIV at 24 weeks, the median delay in detection between the ultrasensitive and standard assays was 18.3 weeks for the nevirapine arm, 15.4 weeks for the maternal arm and 9.4 weeks for the control arm. CONCLUSION: The prolonged inability to detect HIV with standard assays in the context of postnatal antiretroviral prophylaxis suggests that early antiretrovirals may restrict HIV replication sufficiently to lead to missed diagnosis among infected infants. Therefore, repeat virologic testing is warranted beyond the WHO-recommended point of testing at 6 weeks after breastfeeding cessation.
Authors: Denise J Jamieson; Charles S Chasela; Michael G Hudgens; Caroline C King; Athena P Kourtis; Dumbani Kayira; Mina C Hosseinipour; Deborah D Kamwendo; Sascha R Ellington; Jeffrey B Wiener; Susan A Fiscus; Gerald Tegha; Innocent A Mofolo; Dorothy S Sichali; Linda S Adair; Rodney J Knight; Francis Martinson; Zebrone Kacheche; Alice Soko; Irving Hoffman; Charles van der Horst Journal: Lancet Date: 2012-04-26 Impact factor: 79.321
Authors: Julie A E Nelson; J Tyler Hawkins; Maria Schanz; Katie Mollan; Melissa B Miller; John L Schmitz; Susan A Fiscus Journal: J Clin Virol Date: 2014-06-02 Impact factor: 3.168
Authors: Deborah Persaud; Paul E Palumbo; Carrie Ziemniak; Michael D Hughes; Carmelita G Alvero; Katherine Luzuriaga; Ram Yogev; Edmund V Capparelli; Ellen G Chadwick Journal: AIDS Date: 2012-07-31 Impact factor: 4.177
Authors: Tae-Wook Chun; J Shawn Justement; Danielle Murray; Claire W Hallahan; Janine Maenza; Ann C Collier; Prameet M Sheth; Rupert Kaul; Mario Ostrowski; Susan Moir; Colin Kovacs; Anthony S Fauci Journal: AIDS Date: 2010-11-27 Impact factor: 4.177
Authors: Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst Journal: N Engl J Med Date: 2010-06-17 Impact factor: 91.245
Authors: Matthew C Strain; Steven M Lada; Tiffany Luong; Steffney E Rought; Sara Gianella; Valeri H Terry; Celsa A Spina; Christopher H Woelk; Douglas D Richman Journal: PLoS One Date: 2013-04-03 Impact factor: 3.240
Authors: Renate Strehlau; Maria Paximadis; Faeezah Patel; Megan Burke; Karl-Gunter Technau; Stephanie Shiau; Elaine J Abrams; Gayle G Sherman; Gillian Hunt; Johanna Ledwaba; Ahmad H Mazanderani; Caroline T Tiemessen; Louise Kuhn Journal: AIDS Date: 2019-09-01 Impact factor: 4.177
Authors: Anjuli D Wagner; Irene N Njuguna; Ruth A Andere; Lisa M Cranmer; Helen M Okinyi; Sarah Benki-Nugent; Bhavna H Chohan; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace C John-Stewart Journal: AIDS Date: 2017-07-17 Impact factor: 4.177
Authors: Mark M Manak; Linda L Jagodzinski; Ashley Shutt; Jennifer A Malia; Mike Leos; Jason Ouellette; Siriwat Akapirat; Donn L Colby; Nittaya Phanuphak; Leigh Anne Eller; Merlin L Robb; Mark de Souza; Jintanat Ananworanich; Sheila A Peel Journal: J Clin Microbiol Date: 2019-09-24 Impact factor: 5.948
Authors: Raji Balasubramanian; Mary Glenn Fowler; Kenneth Dominguez; Shahin Lockman; Pat A Tookey; Nicole Ngo Giang Huong; Steven Nesheim; Michael D Hughes; Marc Lallemant; Jennifer Tosswill; Nathan Shaffer; Gayle Sherman; Paul Palumbo; David E Shapiro Journal: AIDS Date: 2017-11-28 Impact factor: 4.177
Authors: Patricia M Flynn; Taha E Taha; Mae Cababasay; Kevin Butler; Mary G Fowler; Lynne M Mofenson; Maxensia Owor; Susan Fiscus; Lynda Stranix-Chibanda; Anna Coutsoudis; Devasena Gnanashanmugam; Nahida Chakhtoura; Katie McCarthy; Lisa Frenkel; Ingrid Beck; Cornelius Mukuzunga; Bonus Makanani; Dhayendre Moodley; Teacler Nematadzira; Bangani Kusakara; Sandesh Patil; Tichaona Vhembo; Raziya Bobat; Blandina T Mmbaga; Maysseb Masenya; Mandisa Nyati; Gerhard Theron; Helen Mulenga; David E Shapiro Journal: J Acquir Immune Defic Syndr Date: 2021-10-01 Impact factor: 3.771